Gene locus polymorphisms and expression levels of interleukin-1 in lumbar disc disease: A MOOSE-compliant meta-analysis and immunohistochemical study. Issue 43 (28th October 2022)
- Record Type:
- Journal Article
- Title:
- Gene locus polymorphisms and expression levels of interleukin-1 in lumbar disc disease: A MOOSE-compliant meta-analysis and immunohistochemical study. Issue 43 (28th October 2022)
- Main Title:
- Gene locus polymorphisms and expression levels of interleukin-1 in lumbar disc disease: A MOOSE-compliant meta-analysis and immunohistochemical study
- Authors:
- Yang, Kunxue
Xiao, Qianyi
Zhang, Ruijun
Meng, Dihua
Wang, Jiaqi
Wei, Qingjun
Jiang, Hua - Abstract:
- Abstract : Objective: To investigate the association between interleukin (IL)-1 α (rs1800587), IL-1 β (rs1143634) and IL-1 receptor antagonist (RN) variable number tandem repeat polymorphisms, expression levels and lumbar disc disease (LDD). Methods: All relevant articles were searched from 4 databases including PubMed, Embase, Web of Science and China National Knowledge Infrastructure. Odds ratios (OR) with 95% confidence intervals (CI) were calculated to evaluate the association between IL-1 gene locus polymorphisms (rs1800587 in IL-1 α, rs1143634 in IL-1 β, variable number tandem repeat in interleukin-1 receptor antagonist) and LDD susceptibility. Statistical analysis was conducted by Review Manager (Revman) 5.31 software (Nordic Cochrane Centre, Cochrane Collaboration, Copenhagen, Denmark). Furthermore, qRT-PCR and immunohistochemistry were performed to evaluate IL-1 α, IL-1 β and interleukin-1 receptor antagonist expressions in the normal and degenerated disc. Results: A total of 15 case-control studies (1455 cases and 2362 controls) were included in our meta-analysis. The pooled results suggested that IL-1 α rs1800587 polymorphism was associated with an increased risk of LDD in overall population (T vs. C, OR = 1.21, 95% CI = 1.04–1.40, P = .01). The subgroup analysis found a significant association between IL-1 β rs1143634 polymorphism and LDD in Asian population (T vs. C, OR = 0.61, 95% CI = 0.39–0.96, P = .03). Results of qRT-PCR and immunohistochemistryAbstract : Objective: To investigate the association between interleukin (IL)-1 α (rs1800587), IL-1 β (rs1143634) and IL-1 receptor antagonist (RN) variable number tandem repeat polymorphisms, expression levels and lumbar disc disease (LDD). Methods: All relevant articles were searched from 4 databases including PubMed, Embase, Web of Science and China National Knowledge Infrastructure. Odds ratios (OR) with 95% confidence intervals (CI) were calculated to evaluate the association between IL-1 gene locus polymorphisms (rs1800587 in IL-1 α, rs1143634 in IL-1 β, variable number tandem repeat in interleukin-1 receptor antagonist) and LDD susceptibility. Statistical analysis was conducted by Review Manager (Revman) 5.31 software (Nordic Cochrane Centre, Cochrane Collaboration, Copenhagen, Denmark). Furthermore, qRT-PCR and immunohistochemistry were performed to evaluate IL-1 α, IL-1 β and interleukin-1 receptor antagonist expressions in the normal and degenerated disc. Results: A total of 15 case-control studies (1455 cases and 2362 controls) were included in our meta-analysis. The pooled results suggested that IL-1 α rs1800587 polymorphism was associated with an increased risk of LDD in overall population (T vs. C, OR = 1.21, 95% CI = 1.04–1.40, P = .01). The subgroup analysis found a significant association between IL-1 β rs1143634 polymorphism and LDD in Asian population (T vs. C, OR = 0.61, 95% CI = 0.39–0.96, P = .03). Results of qRT-PCR and immunohistochemistry demonstrated that expressions of IL-1 α and IL-1 β were significantly increased in the degenerated disc. (all P < .05) Conclusion: IL-1 α rs1800587 and IL-1 β rs1143634 polymorphisms were significantly associated with LDD in overall population and in Asian population, respectively. The increased expression levels of IL-1 α and IL-1 β may be the important risk factors for LDD. … (more)
- Is Part Of:
- Medicine. Volume 101:Issue 43(2022)
- Journal:
- Medicine
- Issue:
- Volume 101:Issue 43(2022)
- Issue Display:
- Volume 101, Issue 43 (2022)
- Year:
- 2022
- Volume:
- 101
- Issue:
- 43
- Issue Sort Value:
- 2022-0101-0043-0000
- Page Start:
- e31152
- Page End:
- Publication Date:
- 2022-10-28
- Subjects:
- gene expression -- interleukin-1 -- lumbar disc disease -- meta-analysis -- polymorphism
Medicine -- Periodicals
Medicine -- Periodicals
Médecine -- Périodiques
Geneeskunde
Medicine
Periodicals
Periodicals
610.5 - Journal URLs:
- http://journals.lww.com/md-journal/pages/default.aspx ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&PAGE=toc&D=ovft&MODE=ovid&NEWS=N&AN=00002060-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MD.0000000000031152 ↗
- Languages:
- English
- ISSNs:
- 0025-7974
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5534.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24256.xml